| Financial Year |
March 31 2023 |
| Monetary Funds |
6,423,570,602.14 |
| Held-for-trading Financial Assets |
508,335,052.40 |
| Notes Receivable |
-- |
| Accounts Receivable |
586,061,918.64 |
| Advances to Suppliers |
1,482,493,965.40 |
| Other Receivables |
665,572,530.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
6,864,403.03 |
| Dividend Receivable |
-- |
| Inventories |
7,019,602,698.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
32,591,695.55 |
| Other Current Assets |
1,689,169,467.45 |
| Total Current Assets |
19,893,666,860.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
275,505,016.64 |
| Long-term Equity Investment |
3,704,741,947.06 |
| Investment Properties |
308,412,470.32 |
| Fixed Assetes |
3,994,946,285.10 |
| Under-construction Projects |
400,383,211.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
12,727,696.62 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,211,703,860.95 |
| R&D expenses |
1,603,998.27 |
| Goodwill |
3,661,378.25 |
| Long-Term Deferred and Prepaid Expenses |
2,723,966,587.07 |
| Deferred Income Tax Assets |
1,098,669,174.42 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
36,357,693,027.62 |
| Total Assets |
56,251,359,887.74 |
| Short-Term Loans |
6,372,553,298.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
8,589,332,311.74 |
| Accounts Received In Advance |
81,166,170.34 |
| Employee Compensation Payable |
732,627,921.02 |
| Taxes Payable |
341,879,431.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,544,679,315.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,954,854,846.34 |
| Other Current Liabilities |
459,366,718.60 |
| Sub-Total of Current Liabilities |
25,018,831,530.99 |
| Long-term Loans |
649,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,618,625.20 |
| Deferred Income Tax Liabilities |
117,201,560.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,120,851,021.29 |
| Total Liabilities |
48,139,682,552.28 |
| Paid-In Capital(Or Share Stock) |
9,075,036,993.00 |
| Capital Surplus |
4,292,122,541.86 |
| Surplus Reserve |
1,113,275,260.54 |
| LESS:Treasury Stock |
488,768,297.30 |
| Undistributed Profits |
-6,047,594,382.03 |
| Minority Stockholder's Interest |
165,955,628.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,945,721,707.27 |
| Owner's Equity（Stockholder's Equity） |
8,111,677,335.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
56,251,359,887.74 |
